跳至主要内容
临床试验/ISRCTN37551129
ISRCTN37551129进行中(未招募)Unknown

A study of DNA methylation of bladder cancer markers in urine and bladder tissue of patients with neurogenic lower urinary tract dysfunction

Aristotle University of Thessaloniki0 个研究点目标入组 70 人开始时间: 2023年6月14日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • Neurogenic lower urinary tract dysfunction group:
  • 1. Neurogenic lower urinary tract dysfunction duration for at least 5 years scheduled for cystoscopy, wash cytology and bladder biopsy
  • 2. Age 18 years or older
  • 3. Consent to provide urine sample and bladder tissue
  • Control group (healthy volunteers):
  • 1. Age 18 years or older
  • 2. Consent to provide urine sample

排除标准

  • Neurogenic lower urinary tract dysfunction group:
  • 1. Prior diagnosis and treatment of bladder cancer
  • 2. History of other urinary tract malignancy
  • Control group (healthy volunteers):
  • 1. Lower urinary tract symptoms
  • 2. History of urinary tract malignancy

研究者

相似试验